An innovative platform, called AstroPath, has been developed to analyze large multiplex immunofluorescence (mIF) datasets using celestial object–mapping algorithms to rapidly identify optimized predictive phenotypic signatures. In this webinar, Dr. Janis Taube and Dr. Alexander S. Szalay from Johns Hopkins describe how the AstroPath technology was conceived and developed, share successes applying AstroPath to answering questions about tumor microenvironment-immune system interactions, and provide preliminary results of comparisons across different institutions to assess mIF assay performance.

In a rush? Take a brief moment to read the highlights from this presentation on our blog.